CELLDEX THERAPEUTICS, INC.

Class 005: Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases

Class 005: Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases

Class 005: Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases

Class 005: Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases

Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer

[ Vaccines; Therapeutic vaccines; ] Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; [ Antibody drug conjugates, namely, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the integumentary system and reproductive system; ] Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; ] Therapeutic antibodies and immune system modulators, namely, pharmaceutical preparations for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors, namely, ligands and proteins for stem cells in stem cell mobilization; ] pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, [ immune system stimulators and ] immune system modulators

Class 005: Purified proteins and pharmaceuticals for therapeutic use, all for use in the treatment of cardiovascular disease, immune disorders and inflammation

Class 005: Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disorders, infectious diseases and graft-verus-host disease

Class 005: Attenuated Vibrio cholera strains for administration to humans for delivery of heterologous antigens, for providing protective immunity for the prevention and treatment of infectious diseases

Class 005: Vaccines and pharmaceutical preparations for the prevention or treatment of Vibrio cholera infection

vitrification drying and dehydration preservation services for biologically active materials